Fig 1 - by Natthaya Chuaypen (6726911)

Fig 2 - by Natthaya Chuaypen (6726911)

Fig 5 - by Raghu Arghal (20598093)

“…<p>Fig 5a shows the increase in the death counts of the static vaccination policy over that of the optimal policy as a percentage of the latter. …”

Figure 5 by Jian Jiao (364961)

Potential cleavage site prediction by caspases in different cullin using the software peptide cutter. by Attinder Chadha (11414273)

Subjects:

Proposed model of the study. by Attinder Chadha (11414273)

Subjects:

<i>Eh</i> promotes global neddylation of host cell proteins during <i>Eh</i>-macrophage contact. by Attinder Chadha (11414273)

Subjects:

Rumination time through 120 DIM and milk composition for the first 17 weeks of lactation of control cows and cows supplemented with <i>S</i>. <i>baicalensis</i> extract (SBE) for e... by K. E. Olagaray (6256859)

Sand fly Abundance Reduction (%)^a in the intervention site (Intervention site) during the post-intervention period by collection week, Tayasir, Palestine, July-September... by Samer Sawalha (5890535)

S5 Table - by Gastón F. Alfaro (9080189)

S5 Fig - by Gastón F. Alfaro (9080189)

Effects of T5-1 and T5-12 on TAS2R5 expression during protein synthesis inhibition. by Donghwa Kim (252081)

“…In the presence of CHX, T5-1 caused a decrease in receptor expression with the prolonged exposure, while T5-12 exposure had no significant effect on expression. * , P < 0.01 vs vehicle control.…”

Fig 5 - by Kevin Tsai (197484)

“…Case 1 represents the scenario where the scaling factor <i>n</i> starts with 5 and increase to 12 in 5×10³ simulation time steps, and then decrease to 7 in 5×10³ simulation time steps. …”

Table_5_Volumetric Brain Loss Correlates With a Relapsing MOGAD Disease Course.DOCX by Ariel Rechtman (12283325)

Image_5_Surprise Acts as a Reducer of Outcome Value in Human Reinforcement Learning.TIFF by Motofumi Sumiya (4824993)

Complement anaphylatoxin C5a neuroprotects through regulation of glutamate receptor subunit 2 and -2 by Piali Mukherjee (86993)

“…</p><p></p>ssion as assessed by GluR2 immunostaining in primary cultures from both WT and C5aRKO mice (n = 4). However, while WT primary cultures treated with glutamate and hrC5a (100 nM) which is able to neuroprotect significantly against glutamate neurotoxicity in WT cultures did not show significant decrease in GluR2, primary cultures from C5aR KO mice co-treated with glutamate and hrC5a showed significant decrease in the expression of GluR2. …”

Implementation strategies for PSBI treatment when a referral is not possible. by Gizachew Tadele Tiruneh (8407686)

Folic acid: a potential inhibitor against SARS-CoV-2 nucleocapsid protein by Yu-meng Chen (12575578)

“…This effect was decreased by 8.0% in the presence of SARS-CoV-2 N, indicating that SARS-CoV-2 N inhibits RNAi. …”

A schematic depicting the risk of infection from deposited virus-laden droplets and aerosols on porous fomites. by Eloise Parry-Nweye (7548998)

Anti-C5a reduced IL-12⁺DCs in PBMC and LN. by Ning Ma (155058)

“…<p>(<b>A and B</b>) <b>IL-12⁺DCs cells decreased in PBMC and LN from anti-C5a-treated sepsis.…”